VREOD
Vireo Growth Inc.
$9.95
+0.39 (+4.08%)
At close · Jul 2
Market Cap
$13.76B
Shares
1,360,813,852
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.95
Open$9.95
Day$9.87–10.01
52W$0.32–13.77
Avg vol 30d109K
Short int93 · 0.0% float · 1.0d
Short vol75%
Last earningsMay 12, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+506% above
+
Price vs 50-day avg
+99% above
◦
RSI (14)
62 · neutral
−
MACD trend
negative
◦
52-week position
72% · mid-range
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $5 › 200d $2 — 50d above 200d
+
Institutional flow
+1 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.00% of float · ▼ -99.9% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — 13F breadth
Fundamentals
Strong
+
Revenue growth
+170% Y/Y
+
Gross margin
47%, contracting
+
EPS growth
+44% Y/Y
−
Free cash flow
$-24.6M
−
Balance sheet
net debt $58.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 14, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+506% above
Bullish
Price vs 50-day avg
+99% above
Bullish
RSI (14)
62 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
72% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -99.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $10 · 72%
52-wk high $14
vs 200-day avg +506%
vs 50-day avg +99%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Pro Forma same store sales (excluding Minnesota) growth | 11.3% | Q4 FY2025 | — |
| Pro Forma same store sales growth | 22% | Q4 FY2025 | — |
| Pro Forma wholesale revenue growth | 55% | Q4 FY2025 | — |
| Subordinate voting shares outstanding | 1,177,624,278 | As of December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VREOD
this stock
Vireo Growth Inc.
|
$13.76B | +1523.2% | +170.4% | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.0%
- Net QoQ
- +10.0K sh
- Top holder
- RESOURCES MANAGEMENT CORP…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VREOD | -0.5% | -19.2% | +1558.3% | -0.9% | +1523.2% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.9% | -17.9% | +1550.3% | -0.6% | +1513.9% |